Abstract
Intrdouction: Diagnosis of acute cholangitis using Tokyo Guidelines 2018 (TG18) requires evidence of cholestasis. This is defined as hyperbilirubinemia or any liver enzyme derangement above 1.5 times the upper limit of normal - a rather broad inclusion criteria given that a cholestatic enzyme pattern is considered typical of biliary obstruction. The ratio of ALT and ALP elevation (R-value) characterizes cholestatic, hepatocellular, and mixed liver enzyme derangements. The pattern of liver enzyme derangement in acute cholangitis has not previously been defined.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
